@the_news_21
Adar Poonawalla, CEO of vaccine manufacturing company Serum Institute of India has revealed that trial of Covax has been started in India. The coronavirus vaccine being developed in partnership with American vaccine developer Novavax.
Mr Poonawalla, who had earlier hoped to launch Covovax by June, this afternoon tweeted that it is likely to be launched by September. The Covid jab – found to be 89.3 per cent effective in a UK trial – has been tested against African and UK variants, believed to be much more infections.
“Covovax trials finally begin in India; the vaccine is made through a partnership with @Novavax and @SerumInstIndi. It has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%. Hope to launch by September 2021 (sic)!”, he wrote in a tweet.
